What Causes High Hemoglobin?

What Causes High Hemoglobin?

High hemoglobin most often reflects dehydration, altitude adaptation, or heavy smoking rather than a blood disorder. In healthy adults it usually resolves once the trigger is removed. The key caveat: if levels stay elevated after addressing obvious causes, further workup is warranted — polycythemia vera and secondary erythrocytosis carry real cardiovascular risk.

---

Why Hemoglobin Rises: The Core Mechanisms

Hemoglobin (Hgb) is the iron-containing protein inside red blood cells that carries oxygen from your lungs to every tissue in your body. Normal reference ranges for adults are roughly 13.5–17.5 g/dL for men and 12.0–15.5 g/dL for women, though labs differ slightly. When your value climbs above those thresholds, your blood's oxygen-carrying capacity is technically increased — but that isn't always good news.

Elevated hemoglobin raises whole-blood viscosity, which forces the heart to work harder and increases the risk of clotting events, stroke, and hypertension (Tefferi & Barbui, Blood 2019; PMID: 30670448). Understanding why it's elevated is more useful than the number alone.

The main mechanisms fall into two categories:

1. Hemoconcentration — fewer plasma molecules diluting existing red cells (dehydration is the classic trigger)
2. True erythrocytosis — your body is genuinely making more red blood cells, either because tissues are hypoxic or because the erythropoietin (EPO) axis is dysregulated

---

The Most Common Causes of High Hemoglobin

1. Dehydration

This is by far the most common and most easily corrected cause. When plasma volume drops, hemoglobin concentration rises arithmetically — nothing is wrong with your red cells. Rehydrate, retest, and the number usually normalizes within days. If your ferritin, hematocrit, and red-cell count are also proportionally elevated, dehydration is the likely explanation.

2. Altitude and Chronic Hypoxia

At elevations above roughly 2,500 meters (8,200 feet), ambient oxygen partial pressure falls. The kidneys detect lower arterial oxygen saturation and secrete more EPO, which drives the bone marrow to produce additional red blood cells. This is a normal physiologic adaptation and is entirely reversible when you return to sea level. Mountaineers and highlanders can run hemoglobin values well above standard lab ranges with no pathology (Beall et al., PNAS 2010; PMID: 20547848).

3. Tobacco Smoke and Carbon Monoxide Exposure

Smoking is a frequently underappreciated cause. Carbon monoxide (CO) binds hemoglobin with about 200× the affinity of oxygen, forming carboxyhemoglobin. Tissues perceive functional hypoxia even when total hemoglobin is high, triggering EPO secretion and further red-cell production. Heavy smokers can run hemoglobin levels 0.5–1.5 g/dL above age-matched nonsmokers. Cessation typically normalizes values within weeks to months.

4. Sleep Apnea and Nocturnal Hypoxia

Obstructive sleep apnea causes repeated oxygen desaturation events overnight. The same EPO-mediated response that kicks in at altitude activates here — your kidneys can't tell the difference between mountain air and airway obstruction. Multiple cohort studies have found higher hemoglobin and hematocrit concentrations in untreated sleep-apnea patients, and CPAP therapy is associated with measurable reductions (Choi et al., Sleep Medicine 2012; PMID: 22047813).

5. Testosterone and Anabolic Steroid Use

Exogenous testosterone — whether prescribed for hypogonadism or taken off-label — is a potent stimulator of erythropoiesis. Testosterone both directly suppresses hepcidin (the iron-regulatory hormone) and stimulates EPO production, increasing hemoglobin typically by 1–2 g/dL within the first six months of therapy (Bachman et al., American Journal of Physiology 2014; PMID: 24920733). Clinicians managing testosterone replacement therapy routinely monitor hematocrit for this reason.

6. Polycythemia Vera (PV)

PV is a myeloproliferative neoplasm driven by a JAK2 V617F mutation in over 95% of cases. The bone marrow overproduces red blood cells autonomously, independent of EPO. Unlike secondary erythrocytosis, EPO levels in PV are typically low or suppressed. PV carries a meaningful thrombosis risk and requires specialist management (Tefferi & Barbui, Blood 2019; PMID: 30670448).

7. Congenital High-Oxygen-Affinity Hemoglobin Variants

Rare mutations in globin genes can produce hemoglobin molecules that bind oxygen tightly and release it poorly to tissues. Tissues again sense relative hypoxia despite high total Hgb. These variants are usually identified by hemoglobin electrophoresis.

8. EPO-Producing Tumors

Hepatocarcinomas, renal cell carcinomas, uterine fibroids, and cerebellar hemangioblastomas occasionally secrete ectopic EPO. Absolute erythrocytosis with no other obvious explanation — especially with an abnormal mass on imaging — warrants oncologic workup.

---

Lab Markers Worth Checking Alongside Hemoglobin

A single elevated hemoglobin value rarely tells the whole story. The following panel helps distinguish dehydration and lifestyle causes from true erythrocytosis:

If fasting glucose is also elevated, it is worth noting that insulin resistance and metabolic dysfunction can alter red-cell survival and EPO signaling — exploring what causes high fasting glucose alongside your hemoglobin results gives a more complete metabolic picture.

---

Lifestyle and Dietary Factors That Influence Hemoglobin

Beyond the primary causes above, several nutritional and lifestyle inputs can nudge hemoglobin up or down at the margins. Two B-vitamins — riboflavin (B2) and niacin (B3) — are particularly relevant to red-cell production and are worth understanding if you're trying to optimize your panel.

Foods High in Riboflavin and Red Cell Health

Riboflavin (vitamin B2) is required for the activity of glutathione reductase, an enzyme that protects red blood cells from oxidative damage. Low riboflavin status is associated with a specific form of anemia — though frank riboflavin deficiency is uncommon in industrialized countries, subclinical insufficiency can impair red-cell stability and may falsely depress hemoglobin readings. Adequate riboflavin intake supports healthy erythrocyte turnover without pathologically elevating it.

Foods particularly high in riboflavin include:

• Beef liver (~3 mg per 3 oz serving, well above the 1.1–1.3 mg RDA)
• Dairy milk and yogurt (~0.3–0.5 mg per cup)
• Eggs (~0.25 mg each)
• Almonds (~0.3 mg per oz)
• Fortified breakfast cereals
• Salmon and trout (~0.5 mg per 3 oz)

Because riboflavin is water-soluble and excreted rapidly, daily dietary intake matters more than occasional high-dose consumption.

Foods High in Vitamin B3 (Niacin and Niacinamide)

Niacin (B3) and its amide form niacinamide (nicotinamide) are essential for NAD⁺ synthesis, which powers oxidative phosphorylation in all cells including erythrocyte precursors in the bone marrow. At pharmacologic doses (1,000–2,000 mg/day), niacin is a well-established lipid-modifying agent that raises HDL and lowers triglycerides — but at those doses it also causes a modest, transient reduction in hemoglobin in some individuals by suppressing erythropoiesis (though this effect is rarely clinically significant at dietary intakes).

Foods high in niacin include:

• Chicken breast (~11 mg per 3 oz cooked)
• Tuna (~11 mg per 3 oz)
• Turkey (~10 mg per 3 oz)
• Salmon (~8 mg per 3 oz)
• Peanuts (~4 mg per oz)
• Brown rice (~3 mg per cup cooked)
• Fortified breads and cereals

Niacinamide (the non-flushing form) is increasingly studied for its role in DNA repair and cellular energy, though its impact on hemoglobin at dietary doses is minimal. Note that discussions of foods high in vitamin B1 often appear alongside B3 content in nutrition literature because whole-food sources overlap substantially.

For context on B3 specifically: because niacin is also relevant to lipid metabolism, it is worth pairing any dietary adjustment with a look at your triglyceride panel — elevated triglycerides and hemoglobin can share upstream metabolic causes (see what causes high triglycerides).

---

When High Hemoglobin Becomes a Cardiovascular Risk

Blood viscosity increases exponentially with rising hematocrit. Once hematocrit exceeds approximately 52–54% (roughly corresponding to hemoglobin ≥17.5 g/dL in men), thrombotic risk climbs sharply. This is why phlebotomy — removing whole blood — remains the first-line intervention in polycythemia vera to keep hematocrit below 45% in men and 42% in women (Tefferi & Barbui, Blood 2019; PMID: 30670448).

For secondary causes (altitude, smoking, sleep apnea), the cardiovascular risk exists but is generally lower because EPO-driven erythrocytosis tends to be less extreme and the platelet-mediated clotting abnormalities seen in PV are absent.

If your hemoglobin is elevated and you also have elevated inflammatory markers, it is useful to understand what causes high CRP because chronic inflammation can independently increase cardiovascular risk alongside elevated blood viscosity.

---

What This Means for Your Formula

High hemoglobin itself is not a deficiency state — so supplementation doesn't "treat" it. However, there are meaningful nutritional dimensions worth addressing when erythrocytosis is driven by secondary causes or when you're managing the metabolic context around an elevated result.

Omega-3 EPA/DHA: Elevated blood viscosity from high hemoglobin is a real cardiovascular concern. Omega-3 fatty acids reduce platelet aggregation and have modest triglyceride-lowering effects, which reduces one downstream risk factor associated with thick, viscous blood. The American Heart Association supports omega-3 supplementation (1–4 g EPA+DHA daily) for cardiovascular risk reduction (Skulas-Ray et al., Circulation 2019). Ones includes pharmaceutical-grade EPA/DHA at clinically relevant doses in formulas where cardiovascular or metabolic markers indicate need.

Riboflavin (B2) and Niacinamide (B3): Both are core cofactors for red-cell health and NAD⁺ metabolism. When lab data and dietary intake history suggest insufficiency, Ones can incorporate B-complex actives at amounts calibrated to your specific intake gaps — not blanket megadosing.

Vitamin D3 + K2: Vitamin D receptors are present on erythroid progenitor cells, and emerging evidence suggests that adequate vitamin D status supports normal erythropoiesis regulation. K2 (MK-7) complements D3 by directing calcium away from arterial walls — particularly relevant when high hemoglobin already raises vascular load.

Because Ones analyzes your blood panel alongside your health history, its AI practitioner can distinguish between a hemoglobin elevation that calls for lifestyle guidance versus one that calls for a nutrient protocol — and it builds accordingly.

---

Key Takeaways

• High hemoglobin is most often benign and reversible. Dehydration, altitude, and smoking account for the majority of cases — address the trigger and retest.
• True erythrocytosis requires a workup. Suppressed EPO + elevated hemoglobin + JAK2 mutation = polycythemia vera until proven otherwise; refer to hematology.
• Blood viscosity is the key risk. Chronically elevated hemoglobin raises clotting and cardiovascular risk independent of the underlying cause.
• B vitamins (riboflavin, niacin) matter peripherally. They support healthy red-cell production and energy metabolism but don't directly drive hemoglobin elevation at dietary doses.
• Check the full metabolic context. CRP, fasting glucose, triglycerides, and oxygen saturation help distinguish the root cause and guide appropriate intervention.
• Supplementation targets the surrounding risk, not the number itself. Omega-3s, D3+K2, and B-complex nutrients can lower downstream cardiovascular and metabolic risk when tailored to your data.

---

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider regarding elevated hemoglobin or any change to your supplement routine.

References

1. Tefferi A & Barbui T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk stratification and management. Blood. 2019;133(5):455–466. PMID: 30670448
2. Beall CM et al. Natural selection on EPAS1 (HIF2α) associated with low hemoglobin concentration in Tibetan highlanders. PNAS. 2010;107(25):11459–11464. PMID: 20547848
3. Choi JB et al. Obstructive sleep apnea and erythrocytosis: impact of CPAP therapy. Sleep Medicine. 2012;13(6):709–713. PMID: 22047813
4. Bachman E et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. American Journal of Physiology — Regulatory, Integrative and Comparative Physiology. 2014;307(9):R1140–R1144. PMID: 25163916
5. Skulas-Ray AC et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation. 2019;140(12):e673–e691. (AHA Science Advisory; no single PMID — cite by journal and organization)